IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $275,152,000 | +287.2% | 3,235,949 | +61.4% | 0.34% | +245.9% |
Q2 2020 | $71,056,000 | +1197.8% | 2,004,956 | +393.7% | 0.10% | +653.8% |
Q1 2020 | $5,475,000 | -78.1% | 406,129 | -65.6% | 0.01% | -59.4% |
Q4 2019 | $24,955,000 | +339.9% | 1,179,365 | +175.6% | 0.03% | +255.6% |
Q3 2019 | $5,673,000 | +208.3% | 427,884 | +222.5% | 0.01% | +200.0% |
Q2 2019 | $1,840,000 | -61.7% | 132,684 | -46.9% | 0.00% | -57.1% |
Q1 2019 | $4,803,000 | -87.3% | 250,000 | -90.5% | 0.01% | -88.1% |
Q4 2018 | $37,701,000 | +140.1% | 2,641,970 | +250.5% | 0.06% | +210.5% |
Q3 2018 | $15,701,000 | -82.3% | 753,779 | -79.9% | 0.02% | -83.6% |
Q2 2018 | $88,585,000 | +112.9% | 3,742,519 | +31.4% | 0.12% | +110.9% |
Q1 2018 | $41,614,000 | -60.2% | 2,848,318 | -56.0% | 0.06% | -61.8% |
Q4 2017 | $104,579,000 | +149.0% | 6,471,526 | +115.4% | 0.14% | +125.0% |
Q3 2017 | $42,007,000 | +12.7% | 3,004,762 | -28.8% | 0.06% | -3.0% |
Q2 2017 | $37,258,000 | +221.3% | 4,219,482 | +135.4% | 0.07% | +214.3% |
Q1 2017 | $11,595,000 | +11.6% | 1,792,150 | -36.7% | 0.02% | -4.5% |
Q4 2016 | $10,390,000 | +150.2% | 2,831,007 | +121.6% | 0.02% | +214.3% |
Q3 2016 | $4,153,000 | +588.7% | 1,277,794 | +391.9% | 0.01% | +600.0% |
Q2 2016 | $603,000 | -31.2% | 259,762 | -25.9% | 0.00% | -50.0% |
Q1 2016 | $877,000 | +5058.8% | 350,697 | +3371.9% | 0.00% | – |
Q3 2015 | $17,000 | -99.7% | 10,101 | -99.3% | 0.00% | -100.0% |
Q2 2015 | $6,267,000 | +227.3% | 1,543,648 | +208.7% | 0.01% | +200.0% |
Q1 2015 | $1,915,000 | +4155.6% | 500,000 | +4068.8% | 0.00% | – |
Q3 2014 | $45,000 | -89.7% | 11,994 | -87.4% | 0.00% | -100.0% |
Q4 2013 | $439,000 | +35.1% | 95,331 | +81.6% | 0.00% | 0.0% |
Q3 2013 | $325,000 | -53.2% | 52,487 | -58.9% | 0.00% | -50.0% |
Q2 2013 | $695,000 | – | 127,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |